Power Computing Corporation
Power Computing Corporation was an American computer manufacturer and the first company to produce Macintosh clones, licensed by Apple Computer Inc. The company was founded in November 1993 by Stephen Kahng, a computer engineer best known for designing the Leading Edge Model D.
History[edit | edit source]
Power Computing Corporation was established in November 1993 in Austin, Texas. The company was founded by Stephen Kahng, who had previously designed the Leading Edge Model D, a popular IBM PC clone. Power Computing Corporation was the first company to receive a license from Apple Computer Inc. to produce Macintosh-compatible computers.
The company's first Macintosh clone, the Power 100, was introduced in 1994. It was based on the PowerPC 601 processor and was significantly cheaper than Apple's own Macintosh computers. The Power 100 was followed by several other models, including the Power 120, Power 180, and Power 210.
In 1997, Apple decided to discontinue licensing its operating system to third-party manufacturers, which led to the demise of Power Computing Corporation. The company's assets were sold to Apple in a deal worth $100 million.
Products[edit | edit source]
Power Computing Corporation's products were known for their high performance and low cost. The company's first product, the Power 100, was based on the PowerPC 601 processor and came with 8 MB of RAM and a 500 MB hard drive. It was priced at $1,699, significantly cheaper than Apple's own Macintosh computers.
The company's subsequent products included the Power 120, Power 180, and Power 210. These computers were based on the PowerPC 604 and PowerPC 604e processors and offered even better performance than the Power 100.
Legacy[edit | edit source]
Despite its short lifespan, Power Computing Corporation had a significant impact on the computer industry. The company's success proved that there was a market for Macintosh-compatible computers, and it forced Apple to reconsider its pricing strategy. The company's demise also marked the end of Apple's experiment with licensing its operating system to third-party manufacturers.
 | This United States corporation or company article is a stub. You can help WikiMD by expanding it. |
 | This article about a technological corporation or company is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
